Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2007 Nov 14;2(11):e1176. doi: 10.1371/journal.pone.0001176

Inhibition of Protein Aggregation: Supramolecular Assemblies of Arginine Hold the Key

Utpal Das 1, Gururao Hariprasad 1, Abdul S Ethayathulla 1, Pallavi Manral 1, Taposh K Das 2, Santosh Pasha 3, Anita Mann 4, Munia Ganguli 4, Amit K Verma 5, Rajiv Bhat 5, Sanjeev Kumar Chandrayan 6, Shubbir Ahmed 6, Sujata Sharma 1, Punit Kaur 1, Tej P Singh 1, Alagiri Srinivasan 1,*
Editor: Suzannah Rutherford7
PMCID: PMC2064962  PMID: 18000547

Abstract

Background

Aggregation of unfolded proteins occurs mainly through the exposed hydrophobic surfaces. Any mechanism of inhibition of this aggregation should explain the prevention of these hydrophobic interactions. Though arginine is prevalently used as an aggregation suppressor, its mechanism of action is not clearly understood. We propose a mechanism based on the hydrophobic interactions of arginine.

Methodology

We have analyzed arginine solution for its hydrotropic effect by pyrene solubility and the presence of hydrophobic environment by 1-anilino-8-naphthalene sulfonic acid fluorescence. Mass spectroscopic analyses show that arginine forms molecular clusters in the gas phase and the cluster composition is dependent on the solution conditions. Light scattering studies indicate that arginine exists as clusters in solution. In the presence of arginine, the reverse phase chromatographic elution profile of Alzheimer's amyloid beta 1-42 (Aβ1-42) peptide is modified. Changes in the hydrodynamic volume of Aβ1-42 in the presence of arginine measured by size exclusion chromatography show that arginine binds to Aβ1-42. Arginine increases the solubility of Aβ1-42 peptide in aqueous medium. It decreases the aggregation of Aβ1-42 as observed by atomic force microscopy.

Conclusions

Based on our experimental results we propose that molecular clusters of arginine in aqueous solutions display a hydrophobic surface by the alignment of its three methylene groups. The hydrophobic surfaces present on the proteins interact with the hydrophobic surface presented by the arginine clusters. The masking of hydrophobic surface inhibits protein-protein aggregation. This mechanism is also responsible for the hydrotropic effect of arginine on various compounds. It is also explained why other amino acids fail to inhibit the protein aggregation.

Introduction

Understanding protein aggregation during refolding and expression of proteins in heterologous systems is an important area in basic research as well as in pharmaceutical industry. Protein aggregation is also thought to be associated with several disease processes. It is generally observed that proteins tend to aggregate during in vitro refolding of proteins when the denaturant is being removed [1]. The non-polar residues exposed during denaturation mediate this aggregation [2]. The intra-chain interactions lead to specific folding of polypeptide to assume native conformation. The inter-chain interactions lead to protein aggregation. Favoring the kinetic competition toward intra-chain interactions is an important issue for the generation of proteins in native state. At present, there is no general panacea for this problem. Currently, this problem is being dealt with empirically by the addition of solutes and co-solvents to the protein solutions. Solution additives such as amino acids, salts, osmolytes can modify the solution behavior of the proteins [3 and the references therein]; [4]. Many theories have been proposed to explain the effect of these solution additives for the prevention of protein aggregation [5]–[9], [reviewed in 10]. These mechanisms are based on the interaction of additives with proteins (preferential interaction) [7], [10] and amino acids (amino acid solubility) [10] or the effects on water structure (surface tension) [11]. An attempt has been made to design solution additives using ‘gap effect (similar to osmotic stress) [8]. However, this hypothesis cannot differentiate between a denaturant, a solubilizer, a stabilizer and an aggregation suppressor.

Arginine and proline have been consistently shown to be helpful in preventing protein aggregation due to heating, dilution or partial unfolding [12]–[17]. Arginine does not change the equilibrium of the folding process [15], [17], [18]. It only prevents the association of denatured or partially folded protein [19]–[23]. The hydrotropic effect of arginine on fatty acids has also been documented [24]. Experimental results show that arginine shifts the second virial coefficient to the positive side and suppresses aggregation [25], [26]. Though it has been termed as the most polar amino acid, arginine exhibits hydrotropic effect. Its effect has been observed with proteins, peptides and fatty acids. It has been observed that either the surface tension effect or any other parameters discussed earlier cannot explain the effect of arginine [10]. The explanations proposed so far do not clearly distinguish the interactions of arginine with protein and water. It is also not explained how these are different from the interactions of other additives that do not inhibit protein aggregation. All proposed mechanisms do not consider the hydrophobic interactions, which are mainly responsible for the aggregation of unfolded proteins. It has not been experimentally verified whether arginine combines with the protein or peptide involving the exposed hydrophobic region and/or modulates the hydrophobic interactions. It has been suggested that multimeric forms proline may be responsible for its aggregation inhibitory effects [12], [13]. However, there is no direct evidence in these studies to show that the multimeric forms modulate the hydrophobic properties of the protein. To answer these questions, we have chosen the mouse amyloid Aβ1-42 peptide as the model system because it is insoluble in aqueous medium and its aggregation pattern due to hydrophobic interactions is characterized. Our results show that arginine is present as molecular clusters in solutions. These clusters present a hydrophobic surface by the alignment of its methylene groups. This hydrophobic surface modulates the hydrophobic behavior and prevents hydrophobic surface induced aggregation by binding to Aβ1-42. The results presented here are also the first report of the effects of amino acids on Aβ1-42 solubilization and aggregation.

Results and Discussion

Arginine solutions present hydrophobic environments

The polarity of arginine solutions in 0.02 M sodium phosphate buffer, pH 7.4, (PB) was studied using pyrene solubility and ANS fluorescence characteristics. Pyrene, with its polarity sensing solubility is useful for such studies. Pyrene is sparingly soluble in water. Its solubility increases with the decrease in the polarity of the solvent. Arginine increased the solubility of pyrene in PB in a dose dependent manner (Figure 1A). At 0.5 M arginine concentration, the pyrene solubility increased by three-fold. This hydrotropic effect of arginine has been observed with many other systems as described earlier. However, the mechanism for the hydrotropic effect of arginine is not clear [18], [27]. The part of the arginine molecule, which could be responsible for this effect on the non-polar compounds are its three methylene groups (Cβ, Cγ and Cδ). The hydrophobic interaction of these methylene groups has been observed in other systems as well [28]. This aliphatic side-chain of arginine is shown to interact with the naphthalene [29] or the phenyl [30], [31] ring of ANS. In our experiments, an increase in the intensity of fluorescence emission and a blue shift of the emission λmax has been observed in a concentration dependent manner (Figure 1B). These two changes are characteristics of ANS fluorescence when it is in a hydrophobic environment [32]. Two fold increase in the intensity of fluorescence emission and a blue shift of the emission λmax of 12 nm has been observed with 0.5 M arginine. The hydrotropic effect on pyrene and the ANS fluorescence characteristics indicate that arginine solutions display hydrophobic environment. The interactions resulting in the display of hydrophobic environment are non-covalent in nature and are affected by an increase in solution temperature. Above 45°C, the ANS fluorescence intensity decreased (Figure 1C). The hydrophobic environment of the arginine solutions may interfere with the hydrophobic association of unfolded proteins. Prevented from aggregating, the unfolded proteins remain soluble. The soluble unfolded proteins can fold into native conformation. This would increase the yield of proteins with native conformation.

Figure 1. Non-polar environment in arginine solutions.

Figure 1

Open in a new tab

(A) Pyrene solubility in presence of arginine. The solubility is expressed as fold-increase over the control (solubility in arginine/solubility in buffer). 1 mg pyrene was incubated in arginine solutions at the indicated concentrations at 25°C for 24 h. The absorbance of the supernatant solution was measured at 350 nm. The solubility increases in a dose dependent manner. (B) ANS fluorescence in the presence of arginine. The excitation wavelength was 400 nm and the emission intensity was scanned from 450 to 600 nm. With the increase in arginine concentration, the maximum emission wavelength of ANS (250 µM in PB) decreases (open circle) and relative fluorescence intensity increases (closed circle). (C) Temperature dependence of ANS fluorescence in the presence of 0.2 M arginine. The observed intensity is expressed as % of intensity at 25°C. The intensity decreases above 45°C.

Arginine forms molecular clusters

Interaction of arginine with other molecules involves both its polar and non-polar moieties. Experimental evidences using model compounds show that 3–5 arginine molecules are required to bind one ANS molecule and the binding is cooperative [33]. It is probable that ANS binds to an arginine cluster. Mass spectroscopy is a useful technique to analyze the clustering of amino acids. The previous mass spectroscopic studies of amino acids were carried out in predominantly non-polar or acidic conditions [34], [35]. We have studied the clustering of arginine and other amino acids in PB, under conditions used in our experiments. Arginine formed large clusters in the gas phase. The clustering was dependent on the solution conditions (Figure 2). In water solutions, (pH ∼10.5), largely protonated species of arginine were observed (Figure 2A). At pH 7.4, buffered with sodium phosphate, the clusters were associated with sodium and phosphate groups (Figure 2B). At pH 1.0, less clustering was seen indicating that the carboxylate groups were involved in the cluster formation (Figure 2C). The ionic species observed in the gas phase were dependent on the solution conditions. Similar observations have been made using analytical laser induced liquid beam desorption mass spectrometry [35]. Arginine had higher propensity to form clusters than any other amino acids containing aliphatic chain or many methylene groups [[34], Figure S1]. It has been shown that very large clusters of amino acids can be formed extending to nanometer dimensions. It is also evident that chirally pure amino acids tend to cluster in rod-shaped elongated structures [36]. Direct evidence for existence of clusters of arginine in solution was provided by the light scattering experiments. Rayleigh light scattering by arginine in solutions increased in a concentration dependent manner (Figure 2D). However, it appeared to saturate at higher concentrations beyond 0.5 M. Similar results have been observed for proline in the concentration range of 1–2.5 M. Even at low concentrations of arginine, the scattering intensity increased continuously, whereas this effect was seen with proline only at concentrations above 1 M. This observation is in accordance with the observed efficiency of arginine and proline in preventing protein aggregation. The supramolecular assembly due to noncovalent polar interactions, is expected to be temperature sensitive and collapse at higher temperatures. We have seen that the scattering intensity decreased beyond 45°C (Figure 2D), similar to the decrease in the ANS fluorescence intensity. These results show that ANS binds to the hydrophobic surface on the arginine clusters. When the cluster formation is prevented at above 45°C, the ANS fluorescent intensity decreases.

Figure 2. Molecular clusters of arginine in solution.

Figure 2

Open in a new tab

Electrospray mass spectroscopy of amino acids. The aqueous solutions amino acids at 0.2 M concentrations were used. (A) Arginine exhibits extensive noncovalent protonated clusters when dissolved in water, pH without adjustment was 10.5. (B) ([nArg]Na)+ and ([nArg]H2PO4)+ clusters are observed when arginine is dissolved in sodium phosphate buffer, pH 7.4. (C) Less extensive clustering is seen in acidic solutions at pH 1.0. (D) Increase in Rayleigh light scattering by arginine solution (in PB) is concentration dependent (filled circle) indicating supramolecular assembly. This assembly is temperature sensitive and collapses above 45°C (filled triangle).

Large molecular clusters in solution resemble crystalline state in the intermolecular interactions, orientation of the molecules, self-salvation, etc. Typically, amino acids orient themselves in a peptide-like fashion with N- and C-terminal groups at juxtapositions and the side chains protruding away on both sides [37]. In contrast, arginine stacks in head-to-tail fashion and a hydrophobic column composed of the three methylene groups is seen along one crystallographic axis [[38], Figure S2]. This orientation and packing is observed in many crystal structures of arginine [39], [40]. This unique property of arginine stems from the strong interactions between their guanidium and carboxylate groups of adjacent molecules. These clusters may have conformational properties as observed in crystal structures and be rod shaped as shown by calculations for chirally pure proline [36]. In arginine clusters, the alignment of Cβ, Cγ and Cδ would present a hydrophobic surface similar to that seen in the crystals (Figure S2).

Arginine modulates the hydrophobic interactions of Alzheimer's amyloid beta by binding to it

The hydrophobic environment on the arginine clusters enhanced the hydrotropy of pyrene and caused an increased intensity and a blue-shift in the fluorescence emission maximum of ANS. Arginine has been reported for its hydrotropic effect with wide ranging molecules such as fatty acids [24] and many processes involving proteins, such as denaturation [15], folding [18], stability [41] and solubility [42] and peptide solubility [this study]. The involvement of hydrophobic surfaces is common to all these processes. If arginine can reduce the aggregation induced by hydrophobic surfaces, then the arginine clusters should reduce the overall hydrophobicity of the molecules. We have used Alzheimer's amyloid beta peptide (mouse Aβ1-42) as a model system to study the hydrophobic effect of arginine on the interactions involving hydrophobic surfaces. Aβ1-42 forms protofibrils by hydrophobic interactions. The protofibrils associate to give typical amyloid fibrils [43]. The reduction in the hydrophobic character of Aβ1-42 should be reflected in a changed profile in reverse phase chromatography (RPC), its solubility and aggregation properties. With its hydrophobic regions masked by arginine clusters, the Aβ1-42 should have shorter retention time in RPC in the presence of arginine. In the presence of arginine, the peptide had a shorter retention time (12.5 min, 20% acetonitrile) in the RPC C8 column (Figure 3A) as compared to the peptide without arginine (25 min, 40% acetonitrile). Elution of Aβ1-42 peptide in the early phase of non-polar gradient in the RPC column indicates the less hydrophobic interactions with the C8 column. Thus, arginine reduces the overall-hydrophobicity of the Aβ1-42 molecule.

Figure 3. Arginine modulates the chromatographic profile of Aβ1-42.

Figure 3

Open in a new tab

(A) Reverse phase chromatography of Aβ1-42 peptide. 10 µg of peptide was chromatographed on the RPC C8 column (250×4.6 mm) in the presence and absence arginine. The peptide was eluted with 0–60% acetonitrile linear gradient in PB at a flow rate of 0.7 ml/h and monitored at 257 nm. The arrowhead indicates the start of the gradient. The profiles in the presence and absence of arginine are indicated. (B) Size exclusion chromatography. 10 µg of Aβ1-42 was chromatographed on SMART Superdex G-75 column with and without arginine. The monomeric and tetrameric forms of Aβ1-42 elutes with larger hydrodynamic volume in the presence of arginine (red curve) compared with the control (blue curve). (The molecular weights are indicated by arrows).

To mask the hydrophobic surfaces of Aβ1-42, the arginine has to bind to these surfaces. Arginine exists in clusters and these clusters have a hydrophobic surface. It is expected that arginine clusters bind to Aβ1-42. Under these conditions the hydrodynamic volume of Aβ1-42 should increase significantly. The size exclusion chromatographic experiments showed that the monomeric form of Aβ1-42 eluted with a mass corresponding to 6.0 kDa in the presence of 0.2 M arginine as compared to 4.5 kDa without arginine (Figure 3B). This indicated that nine arginine molecules have bound to a single Aβ1-42 molecule. The 42 mer form of Aβ is known to form tetramer more predominantly than dimer or trimer [44]. We observed mostly monomeric and tetrameric forms. The tetrameric form in the presence of arginine was larger than the control by 6.0 kDa. This corresponded to an increase in molecular mass equivalent to 36 arginine molecules. The largest peak corresponds to the void volume fraction. These results clearly show that a large number of arginine molecules bind to Aβ1-42 to mask the hydrophobic surfaces. This experiment can not be carried out at higher temperatures, since at higher temperatures Aβ1-42 aggregates at faster rates [45].

Arginine increases Aβ1-42 solubility and decreases fibrillar formation

One of the consequences of interactions between Aβ1-42 and clusters of arginine molecules should be the increased hydrotropy of the peptide in presence of arginine as with pyrene and decreased aggregation as with proteins. We have determined the Aβ solubility and aggregation in the presence of various amino acids. Arginine and proline were the two amino acids that enhanced the solubility of Aβ1-42 significantly (Figure 4) and decreased the Aβ1-42 aggregation in aqueous medium (Figure 5A, 5B). There was a parallelism between the solubility and inhibition of aggregation. The amino acids having no effect on the solubility did not prevent aggregation either (Figure S3). At equimolar concentrations, arginine was more effective than proline. These observations are analogous to the inhibition of aggregation of proteins due to hydrophobic forces. If it were the hydrophobic environment presented by the molecular assembly of these two amino acids that is responsible for the hydrotropic and anti-aggregation effect, then the nonpolar amino acids would be expected to be more effective. On the contrary, our results showed that nonpolar aliphatic amino acids were not effective either in increasing the solubility (Figure 4) or in inhibiting the Aβ1-42 aggregation, in particular (Figure S3, A, B and C) and the protein aggregation, in general [15]. The intensity of ANS fluorescence was not affected by the presence of amino acids having long aliphatic chains and nonpolar amino acids (up to 0.2 M) (Figure S4). It has been shown using model systems that ANS binds preferentially to arginine than any other basic amino acids [33]. These amino acids did not display an equal propensity to form clusters in aqueous medium as arginine and proline [[34], [35], Figure S1].

Figure 4. The effect of amino acids on the solubility of Aβ1-42.

Figure 4

Open in a new tab

The amino acids are indicated by single letter code. Data are given as mean±SE of four experiments in duplicates with 0.2 M amino acids. Diagonal upward bar - 0.5 M proline; vertical bar - 1.0 M proline (mean of 2 experiments). With arginine, dark shade - 0.3 M arginine; diagonal downward bar - 0.4 M arginine; horizontal bar - 0.5 M arginine (mean of 2 experiments).

Figure 5. Inhibition of Aβ1-42 fibril formation by arginine and praline.

Figure 5

Open in a new tab

AFM images (3×3 micron). Aβ1-42 was incubated in PB at 25°C for 24 h. (A) Inhibition of aggregation of Aβ1-42 by 0.2 M arginine. (B) Inhibition of aggregation of Aβ1-42 by 0.2 M proline. (C) Complete solubilization of Aβ1-42 at pH 10.5. No fibrils were observed. (D) Control experiment in which the fibrils formed. (Inset) Transmission electron micrograph of 24 h control sample at higher magnification (22,000×) showing spherical aggregating units.

The aggregation of unfolded proteins and amyloid type proteins involve hydrophobic surfaces. In such cases, interactions of the hydrophobic surfaces provided by the clusters of arginine or proline would be more effective than the interaction between protein hydrophobic surface and an individual molecule of these two amino acids. Secondly, a hydrophobic surface of large dimensions cannot be maintained in an aqueous environment. The crystal structures of arginine and proline revealed the presence of hydrophobic columns along one of its crystallographic axis [38], [46]. Spectroscopic experiments have also demonstrated the presence of such assemblies in solutions [[34], [35]; present study]. Small amino acids do not have enough methylene groups that could provide a hydrophobic surface. The long-chain (lysine, methionine) amino acids have not been observed to have stacking interactions even at supersaturating concentrations during crystallizations [37], [47]–[49]. This could be due to the absence of side chain groups, which can have strong, multiple interactions and form a planar structure such as guanidium group. Multiple polar interactions and planar structures of the side chains help in stacking and having strong interactions with neighboring molecules in aqueous medium. The side chains of other amino acids are not aligned parallel to each other in their crystal-packing, ruling out the possibility of stacking. We also did not observe an increase in ANS fluorescence intensity in the presence of these amino acids indicating the absence of any hydrophobic surfaces. In the crystal structure of nonpolar amino acids, it is seen that their side chains are not parallel, have different conformations and side chains do not stack [50]–[52]. Without stacking, tail-to-tail interactions of these amino acids alone will be very weak to maintain a large molecular assembly to present a hydrophobic surface in aqueous medium. As these amino acids are polar at one end only, they are expected to form micellar structures rather than an open-ended bilayer structure in aqueous solution. In micellar structures, the hydrophobic moieties are not exposed to bulk aqueous medium. Hence, they are not available for interaction with the hydrophobic surfaces of the proteins. With aromatic amino acids, the dimensions of the side chains, thereby the hydrophobic surface may be too large to be exposed to water. These observations are based on the crystallographic studies of amino acids and their complexes with other ions and amino acids. These studies do not show any evidence of stacking interactions except for arginine and proline. There are crystallographic studies reporting stacking interactions between leucine residues when free leucine binds to the binding site of leucine/valine/isoleucine binding protein [53]. This may not be an analogous situation of leucine molecules interacting in aqueous solutions. The leucine and other amino acids in the binding site of the protein have fixed molecular orientations such that the interacting free ligand does not have many conformational probabilities. With the exclusion of water during binding, the interactions are quite unlike the interactions in water. We have observed that at 55°C, the fluorescence intensity (Figure 1C) and the light scattering (Figure 2D) have reached almost the minimum. In the same temperature range, proline also loses its inhibitory effect on protein aggregation [46]. In this temperature range, the polar interactions are affected more than the hydrophobic ones. Perhaps the cluster formations by these amino acids using polar interactions are affected thereby eliminating the anti-aggregation effect. It is common to find that the aggregates of small molecules and not the monomeric forms as the biologically active entities. The mechanism of action of detergents is well known in many applications. The other example is the nuclear aggregates of polyamines [54]. It is the aggregates and not the monomeric forms of polyamines that protect the genomic DNA against DNase I [55].

Our results show that arginine presents a hydrophobic environment in solutions, exists in supramolecular assemblies and binds to Aβ1-42. This binding modulates the hydrophobicity of Aβ1-42 molecule and suppresses fibrillar formation.

Materials and Methods

Synthesis of Aβ1-42

Mouse Aβ1-42, DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAII GLMVGGVVIA was synthesized using Fmoc chemistry on an automated peptide synthesizer (model PS3, Protein Technologies, USA). The peptide was purified on a ProRPC C-18 column in a FPLC system. The peptide was stored at −20°C as lyophilized powder. Before use, the peptide was dissolved in 0.01 M NaOH and centrifuged at 16,000 g for 10 min at 4°C.

Pyrene solubility

The solubility of pyrene was measured at various concentrations of arginine. Arginine at indicated concentrations in PB was incubated with 1 mg of pyrene at 25°C for 24 h. The solutions were centrifuged at 16,000 g for 15 min at 25°C. The absorbance of the supernatant was measured at 350 nm.

Fluorescence spectroscopy

The changes in the emission wavelength maximum and fluorescence intensity of 1-anilino-8-naphthalene sulfonic acid (ANS) were measured in the presence of various concentrations of arginine, lysine, methionine and leucine in PB at 25°C. The fluorescence measurements were made using a Varian Cary Eclipse fluorescence spectrophotometer (Varian, USA). The excitation was at 400 nm and the emission spectra were recorded from 450–600 nm with a bandwidth of 5 nm. Blanks contained only the amino acids at the corresponding concentrations.

The temperature dependence of ANS fluorescence in presence of 0.2 M arginine were measured by changing the cuvette temperature by circulating water, maintained at different temperatures with an accuracy of ±0.1°C. The cuvettes were allowed to thermally equilibrate for 5 min before taking the reading.

Mass spectroscopy

The amino acid solutions were prepared in MilliQ water and the pH was adjusted with dilute H3PO4 or PB. The concentration of the amino acid was 0.2 M. All mass spectra were obtained using a nanospray ESI-Q-TOF mass spectrometer (QStar XL, Applied Biosystems Inc., USA). The signal was tuned on the protonated dimer of arginine clusters. Tuning on higher-order clusters did not result in either the signal strength or change in the distribution of clusters. The settings used in this study were as follows: curtain gas flow 0.70 ml/min; the ion spray voltage 900 V; the declustering potentials DP1 100 V and DP2, 12 V; the focusing potential 100 V. The positive ion spectra were obtained for 5 min in acquire mode. Protonated dimers and trimers always appeared along with protonated monomers.

Light scattering

Rayleigh scattering of 400 nm light was measured at 90° geometry on a Jasco J-810 spectrometer fitted with a Jasco FMO427 fluorescence emission monochromator attachment. The excitation monochromator was set at 400 nm and the emission was scanned between 385 nm and 410 nm, with the bandpass set at 10 nm for both monochromators. For room temperature measurements, five scans were performed for each sample and the measurement at 400 nm was noted and averaged. Arginine solutions were prepared in PB at indicated concentrations. Triplicate samples were used at each concentration. Similarly, for measurements at different temperatures, the peltier attachment of the spectrometer was set to the desired temperature before the performance of the five scans.

Reverse Phase Chromatography

The Aβ1-42 peptide was dissolved in 0.01 M NaOH and centrifuged at 16,000 g for 10 min at room temperature. The pH was adjusted to 7.4 by the addition of PB with and without 0.2 M arginine. The final concentration of the peptide was 200 µg/ml. The solutions were incubated for 3 h at room temperature. 0.05 ml of the solution was loaded on to the RPC C8 column (250×4.6 mm) (Phenomenex, USA) equilibrated with PB using a Shimadzu HPLC set up (Model SCL-10 AVP, Shimadzu, Japan). A linear gradient of acetonitrile from 0% to 60% in 30 min was applied at a flow rate of 0.7 ml/min. For the treated sample, the equilibration and elution buffers contained 0.2 M arginine. The sample was monitored at 257 nm.

Size exclusion chromatography

Chromatography was performed on a SMART analytical Superdex G75 column on a SMART system from Amersham Pharmacia (30 cm length, bed volume 2.4 ml) using a flow rate of 100 µl/min and with monitoring of absorption of elution carried out at 257 nm (corresponding to the absorption of phenylalanine). The column was equilibrated with PB or with PB containing 0.2 M arginine before loading of peptide samples (10 µg in 50 µl). The peptide was incubated for 1 h with 0.2 M arginine before loading.

Aβ1-42 solubility measurements

The L-amino acids (Sigma Chemical Co., USA) in 10 mM phosphate buffer, pH 7.4 (PB) were added to alkali-solubilized Aβ1-42 to give a final concentration of 0.2 M amino acids and 10 µM Aβ1-42. After 30 min incubation at 25°C, the tubes were centrifuged at 16,000 g for 15 min. The supernatant was made alkaline by the addition of 0.05 M NaOH. The absorbance at 257 nm was read for the supernatant fractions (Lambda 25 model, Perkin Elmer, USA). The absorbance was compared with the 10 µM Aβ1-42 in 0.01 M NaOH. 0.2 M solutions of tyrosine, tryptophan, glutamic acid and phenylalanine could not be prepared due to their insolubility in PB.

Atomic Force Microscopy (AFM)

All images were obtained in the MAC mode to ensure minimum sample damage using a PicoSPM equipment (Molecular Imaging, USA). AuCr coated MAC cantilevers, 225 µm long, resonance frequency of 83 kHz and force constant of 2.8 N/m were used for imaging. Scan speed used in was 1 line/sec. 2 µl of 10 µM Aβ1-42 solution with and without 0.2 M amino acids was deposited on a freshly cleaved piece of mica (1×1 cm) and allowed to stand for 2 min. Imaging was carried out in air. Minimum image processing (first order flattening and brightness contrast) was used.

Transmission electron microscopy (TEM)

Aβ1-42 at 10 µM concentration in PB was incubated for 24 h at 25°C. The samples were agitated gently before being spotted on a 400-mesh carbon-coated EM grid for two minutes and stained with 1% uranyl acetate for 1 min. Micrographs were recorded using transmission electron microscope (Morgagni 268D, FEI-Philips, USA).

Crystal packing diagram

The coordinates were taken from Karle and Karle [38] and visualized using the program Mercury (Version 1.4) [56]. The view is along the b-axis.

Supporting Information

Figure S1

Mass spectra of methionine, lysine, leucine and proline. 0.2 M solutions in PB were used. The scan conditions were the same as used for arginine (Figure 2). (A) methionine, (B) lysine and (C) leucine do not display higher order clustering as proline (D) or arginine (Figure 2).

(9.27 MB TIF)

Click here for additional data file. (8.8MB, tif)
Figure S2

The crystal packing of arginine molecule shown in sphere model. The yellow color indicates the hydrophobic regions of arginine and the solvent molecules were shown in orange color. The coordinates were taken from Karle and Karle (see ref) and visualized using the program Mercury (Version 1.4). The view is along the b-axis.

(0.17 MB TIF)

Click here for additional data file. (169.1KB, tif)
Figure S3

AFM images of Aβ1-42 in the presence of 0.2 M amino acids. (A) methionine after 24 h; (B) leucine after 24 h; (C) lysine after 24 h. (D) arginine after 48 h. Only arginine prevents Aβ1-42 aggregation significantly. Legend as in the figure 5.

(2.45 MB TIF)

Click here for additional data file. (2.3MB, tif)
Figure S4

ANS fluorescence in presence of arginine, methionine, lysine and leucine. The excitation wavelength was 400 nm. ANS fluorescent intensity was measured at the emission λmax for the respective amino acids at different concentrations. ANS was present at 250 µM concentration. The amino acids of respective concentration formed the control. Legend as in figure 1.

(8.49 MB TIF)

Click here for additional data file. (8.1MB, tif)

Acknowledgments

We thank Dr. P. Guptasarma, Institute of Microbial Technology, Chandigarh for discussion and for access to light scattering and size-exclusion chromatographic systems in his laboratory. UD, ASE and MG acknowledge the financial help from Council for Scientific and Industrial Research, Government of India. PM acknowledges Indian Council of Medical research, Government of India for financial help.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This work has been supported by a research grant to AS from the Department of Biotechnology, Government of India.

References

  • 1.Goldberg ME. The second translation of the genetic message: protein folding and assembly. Trends Biochem Sci. 1985;10:388–391. [Google Scholar]
  • 2.Brems DN, Plaisted SM, Kaufmann EW, Lund M, Lehrmann SR. Helical formation in isolated fragments of bovine growth hormone. Biochemistry. 1987;26:7774–7778. doi: 10.1021/bi00398a036. [DOI] [PubMed] [Google Scholar]
  • 3.Bondos SE, Bicknell A. Detection and prevention of protein aggregation before, during, and after purification. Anal Biochem. 2003;316:223–231. doi: 10.1016/s0003-2697(03)00059-9. [DOI] [PubMed] [Google Scholar]
  • 4.Lee SH, Carpenter JF, Chang BS, Randolph TW, Kim YS. Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure. Protein Sci. 2006;15:304–313. doi: 10.1110/ps.051813506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kirkwood JG, Buff FP. The statistical mechanical theory of solutions. J Chem Phys. 1951;19:774–777. [Google Scholar]
  • 6.Timasheff SN. Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated. Adv Protein Chem. 1998;51:355–431. doi: 10.1016/s0065-3233(08)60656-7. [DOI] [PubMed] [Google Scholar]
  • 7.Colombo MF, Rau DC, Parsegian A. Protein solvation in allosteric regulation: A water effect on hemoglobin. Science. 1992;256:655–659. doi: 10.1126/science.1585178. [DOI] [PubMed] [Google Scholar]
  • 8.Baynes BM, Trout BL. Rational design of solution additives for the preventing of protein aggregation. Biophys J. 2004;87:1631–1639. doi: 10.1529/biophysj.104.042473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shimizu S. Estimating hydration changes upon biomolecular reactions from osmotic stress, high pressure, and preferential hydration experiments. Proc Natl Acad Sci U S A. 2004;101:1195–1199. doi: 10.1073/pnas.0305836101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, et al. Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys Chem. 2007;127:1–8. doi: 10.1016/j.bpc.2006.12.007. [DOI] [PubMed] [Google Scholar]
  • 11.Melander W, Horváth C. Salt effect on hydrophobic interactions in precipitation and chromatography of proteins: an interpretation of the lyotropic series. Arch Biochem Biophys. 1977;183:200–215. doi: 10.1016/0003-9861(77)90434-9. [DOI] [PubMed] [Google Scholar]
  • 12.Samuel D, Kumar TKS, Jayaraman G, Yang PW, Yu C. Proline is a protein stabilizing solute. Biochem Mol Biol Int. 1997;41:235–242. doi: 10.1080/15216549700201241. [DOI] [PubMed] [Google Scholar]
  • 13.Schobert B, Tschessche H. Unusual solution properties of proline and its interaction with proteins. Biochim Biophys Acta. 1978;541:270–277. doi: 10.1016/0304-4165(78)90400-2. [DOI] [PubMed] [Google Scholar]
  • 14.Srinivas V, Balasubramanian D. Proline is a compatible hydrotrope. Langmuir. 1995;11:2830–2833. [Google Scholar]
  • 15.Shiraki K, Kudou M, Fujiwara S, Imanaka T, Takagi M. Biophysical effect of amino acids on the prevention of protein aggregation. J Biochem (Tokyo) 2002;132:591–595. doi: 10.1093/oxfordjournals.jbchem.a003261. [DOI] [PubMed] [Google Scholar]
  • 16.Reddy KRC, Lilie H, Rudolph R, Lange C. L-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci. 2005;14:929–935. doi: 10.1110/ps.041085005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Taneja S, Ahmad F. Increased thermal stability of proteins in the presence of amino acids. Biochem J. 1994;303:147–153. doi: 10.1042/bj3030147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Arakawa T, Tsumoto K. The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun. 2003;304:148–152. doi: 10.1016/s0006-291x(03)00578-3. [DOI] [PubMed] [Google Scholar]
  • 19.Rinas U, Risse B, Jaenicke R, Abel KJ, Zettlmeissl G. Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Biol Chem Hoppe-Seyler. 1990;371:49–56. doi: 10.1515/bchm3.1990.371.1.49. [DOI] [PubMed] [Google Scholar]
  • 20.Buchner J, Rudolph R. Renaturation, purification and characterization of recombinant fab-fragments produced in Escherichia coli. Biotechnology. 1991;9:157–162. doi: 10.1038/nbt0291-157. [DOI] [PubMed] [Google Scholar]
  • 21.Arora D, Khanna N. Method for increasing the yield of properly folded recombinant human γ-interferon from inclusion bodies. J Biotechnol. 1996;52:127–133. doi: 10.1016/s0168-1656(96)01636-7. [DOI] [PubMed] [Google Scholar]
  • 22.Armstrong N, de Lencastre A, Gouaux E. A new protein folding screen: application to the ligand binding domains of a glutamate and kainite receptor and to lysozyme and carbonic anhydrase. Protein Sci. 1999;8:1475–1483. doi: 10.1110/ps.8.7.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Baynes BM, Wang DIC, Trout BL. Role of arginine in the stabilization of proteins against aggregation. Biochemistry. 2005;44:4919–4925. doi: 10.1021/bi047528r. [DOI] [PubMed] [Google Scholar]
  • 24.Hirai A, Kawasaki H, Tanaka S, Nemoto N, Suzuki M, et al. Effects of l-arginine on aggregates of fatty-acid/potassium soap in the aqueous media. Colloid Polym Sci. 2006;284:520–528. [Google Scholar]
  • 25.Ho JG, Middelberg AP, Ramage P, Kocher HP. The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient. Protein Sci. 2003;12:708–716. doi: 10.1110/ps.0233703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Valente JJ, Verma KS, Manning MC, Wilson WW, Henry CS. Second virial coefficient studies of cosolvent-induced protein self-interaction. Biophys J. 2005;89:4211–4218. doi: 10.1529/biophysj.105.068551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tsumoto K, Ejima D, Kita Y, Arakawa T. Why is Arginine Effective in Suppressing Aggregation? Protein & Peptide Letters. 2005;12:613–619. doi: 10.2174/0929866054696109. [DOI] [PubMed] [Google Scholar]
  • 28.Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, et al. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science. 1996;273:464–471. doi: 10.1126/science.273.5274.464. [DOI] [PubMed] [Google Scholar]
  • 29.Schonbrunn E, Eschenburg S, Luger K, Kalsch W, Amrhein N. Structural basis for the interaction of the fluorescence probe 8-anilino-1-naphthalene sulfonate (ANS) with the antibiotic target MurA. Proc Natl Acad Sci U S A. 2000;97:6345–6349. doi: 10.1073/pnas.120120397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ory JJ, Banaszak LJ. Studies of the ligand binding reaction of adipocyte lipid binding protein using the fluorescent probe 8-anilino-1-naphthalene sulfonate. Biophys J. 1999;77:1107–1116. doi: 10.1016/S0006-3495(99)76961-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lartigue A, Gruez A, Spinelli S, Riviere S, Brossut R, et al. The crystal structure of a cockroach pheromone-binding protein suggests a new ligand binding and release mechanism. J Biol Chem. 2003;278:30213–30218. doi: 10.1074/jbc.M304688200. [DOI] [PubMed] [Google Scholar]
  • 32.Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J Mol Biol. 1965;13:482–495. doi: 10.1016/s0022-2836(65)80111-5. [DOI] [PubMed] [Google Scholar]
  • 33.Ichimura S, Zama M. The interaction of 8-anilino-1-naphthalenesulfonate with polylysine and polyarginine. Biopolymers. 1977;16:1449–1464. doi: 10.1002/bip.1977.360160706. [DOI] [PubMed] [Google Scholar]
  • 34.Julian RR, Hodyss R, Beauchamp JL. Cooperative salt bridge stabilization of Gas-phase zwitterions in neutral arginine clusters. J Am Chem Soc. 2001;123:3577–3583. doi: 10.1021/ja003105a. [DOI] [PubMed] [Google Scholar]
  • 35.Charvat A, Lugovoj E, Faubel M, Abel B. Analytical laser induced liquid beam desorption mass spectrometry of protonated amino acids and their non-covalently bound aggregates. Eur Phys J D. 2002;20:573–582. [Google Scholar]
  • 36.Myung S, Fioroni M, Julian RR, Koeniger SL, Baik MH, et al. Chirally directed formation of nanometer-scale proline clusters. J Am Chem Soc. 2006;128:10833–10839. doi: 10.1021/ja0622711. [DOI] [PubMed] [Google Scholar]
  • 37.Suresh CG, Vijayan M. X-ray studies on crystalline complexes involving amino acids and peptides. VIII. Head-to-tail arrangement and a specific interaction in the crystal structure of L-arginine acetate. Int J Pep Res. 1983;21:223–226. [PubMed] [Google Scholar]
  • 38.Karle J, Karle IL. An application of the symbolic addition method to the structure of L-arginine dehydrate. Acta Cryst. 1964;17:835–841. [Google Scholar]
  • 39.Saenger W, Wagner KG. An X-ray Study of the Hydrogen Bonding in the Crystalline L-Arginine Phosphate monohydrate complex. Acta Crystallogr. 1972;B28:2237–2244. [Google Scholar]
  • 40.Recacha R, Verdaguer N, Subirana JA. Structure and supramolecular packing features of the dipeptide Arg-Val acetate. J Pept Res. 1997;50:388–392. doi: 10.1111/j.1399-3011.1997.tb01199.x. [DOI] [PubMed] [Google Scholar]
  • 41.Ishibashi M, Tsumoto K, Ejima D, Arakawa T, Tokunaga M. Characterization of Arginine as a Solvent Additive: A Halophilic Enzyme as a Model Protein. Protein & Peptide Lett. 2005;12:649–653. doi: 10.2174/0929866054696136. [DOI] [PubMed] [Google Scholar]
  • 42.Hsih MH, Kuo JC, Tsai HJ. Optimization of the solubilization and renaturation of fish growth hormone produced by Escherichia coli. Appl Microbiol Biotechnol. 1997;48:66–72. doi: 10.1007/s002530051016. [DOI] [PubMed] [Google Scholar]
  • 43.Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, et al. Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A. 2003;100:330–335. doi: 10.1073/pnas.222681699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chen YR, Glabe CG. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem. 2006;281:24414–24422. doi: 10.1074/jbc.M602363200. [DOI] [PubMed] [Google Scholar]
  • 45.Gursky O, Aleshkov S. Temperature dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation. Biochim Biophys Acta. 2000;1476:93–102. doi: 10.1016/s0167-4838(99)00228-9. [DOI] [PubMed] [Google Scholar]
  • 46.Samuel D, Kumar TKS, Ganesh G, Jayaraman G, Yang PW, et al. Proline inhibits aggregation during protein refolding. Protein Sci. 2000;9:344–352. doi: 10.1110/ps.9.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wright DA, Marsh RE. The Crystal Structure of L-Lysine Monohydrochloride Dihydrate. Acta Crystallogr. 1962;15:54–64. [Google Scholar]
  • 48.Koetzle TF, Frey MN, Lehmann MS, Hamilton WC. Precision Neutron Diffraction structure of Determination of protein and Nucleic Acid Components. XIII. Molecular and Crystal Structure of the Amino Acid L-Glutamine. Acta Crystallogr. 1973;B29:2571–2575. [Google Scholar]
  • 49.Torii K, Iitaka Y. Crystal Structures and Molecular Conformations of L-Methionine and L-Norleucine. Acta Crystallogr. 1973;B29:2799–2807. [Google Scholar]
  • 50.Subramanian E. The Crystal Structure of L-Leucine Hydrobromide. Acta Crystallogr. 1967;22:910–917. doi: 10.1107/s0365110x67001768. [DOI] [PubMed] [Google Scholar]
  • 51.Torii K, Iitaka Y. The Crystal Structure of L-Valine. Acta Crystallogr. 1970;B26:1317–1326. doi: 10.1107/s0567740870004065. [DOI] [PubMed] [Google Scholar]
  • 52.Torii K, Iitaka Y. The Crystal Structure of L-Isoleucine. Acta Crystallogr. 1971;B27:2237–2246. [Google Scholar]
  • 53.Sack JS, Saper MA, Quiocho FA. Periplasmic binding protein structure and function. Refined X-ray structures of the leucine/isoleucine/valine-binding protein and its complex with leucine. J Mol Biol. 1989;206:171–191. doi: 10.1016/0022-2836(89)90531-7. [DOI] [PubMed] [Google Scholar]
  • 54.D'Agostino L, Di Luccia A. Polyamines interact with DNA as molecular aggregates. Eur J Biochem. 2002;269:4317–4325. doi: 10.1046/j.1432-1033.2002.03128.x. [DOI] [PubMed] [Google Scholar]
  • 55.D'Agostino L, di Pietro M, Di Luccia A. Nuclear aggregates of polyamines are supramolecular structures that play a crucial role in genomic DNA protection and conformation. FEBS J. 2005;272:3777–3787. doi: 10.1111/j.1742-4658.2005.04782.x. [DOI] [PubMed] [Google Scholar]
  • 56.Macrae CF, Edgington PR, McCabe P, Pidcock E, Shields GP, et al. Mercury: visualization and analysis of crystal structures. J Appl Cryst. 2006;39:453–457. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1

Mass spectra of methionine, lysine, leucine and proline. 0.2 M solutions in PB were used. The scan conditions were the same as used for arginine (Figure 2). (A) methionine, (B) lysine and (C) leucine do not display higher order clustering as proline (D) or arginine (Figure 2).

(9.27 MB TIF)

Click here for additional data file. (8.8MB, tif)
Figure S2

The crystal packing of arginine molecule shown in sphere model. The yellow color indicates the hydrophobic regions of arginine and the solvent molecules were shown in orange color. The coordinates were taken from Karle and Karle (see ref) and visualized using the program Mercury (Version 1.4). The view is along the b-axis.

(0.17 MB TIF)

Click here for additional data file. (169.1KB, tif)
Figure S3

AFM images of Aβ1-42 in the presence of 0.2 M amino acids. (A) methionine after 24 h; (B) leucine after 24 h; (C) lysine after 24 h. (D) arginine after 48 h. Only arginine prevents Aβ1-42 aggregation significantly. Legend as in the figure 5.

(2.45 MB TIF)

Click here for additional data file. (2.3MB, tif)
Figure S4

ANS fluorescence in presence of arginine, methionine, lysine and leucine. The excitation wavelength was 400 nm. ANS fluorescent intensity was measured at the emission λmax for the respective amino acids at different concentrations. ANS was present at 250 µM concentration. The amino acids of respective concentration formed the control. Legend as in figure 1.

(8.49 MB TIF)

Click here for additional data file. (8.1MB, tif)

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES